An interventional study of Mixed thickness tunnel access with connective tissue graft and Modified Coronally Advanced Tunnel Technique with connective tissue graft in Recession, Gingival, sponsored by Cairo University. Active, not recruiting at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 36 studies in Gingival Recession by Cairo University — 14 open to participants now, 15 under way, 2 of them phase 3. Gingival Recession · Cairo University.
Among the 36 studies in Gingival Recession by Cairo University, this one is the 3rd largest by enrollment, is one of 4 that started in 2024, is one of 31 with no phase, reaches primary completion later than 13 of the 14 other live ones, and was the 36th registered.
430 studies on the registry are indexed under Gingival Recession; 106 are open to participants now.
Browse Gingival Recession studies →14 of the 36 studies in Gingival Recession by Cairo University are open now, in 1 country. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 18+
Cairo University · Sites in Egypt
Ages 18+
Cairo University · Sites in Egypt
Ages 18–60 · Healthy volunteers
Cairo University · Sites in Egypt
Ages 18+ · Healthy volunteers
Cairo University · Sites in Egypt
Ages 18–60 · Healthy volunteers
By country, each count listing its studies:
Of the 63 Gingival Recession studies recruiting now, 30 (48%) set no upper age limit and 30 (48%) stop at 75 or younger; 1 takes children under 18; 36 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
36 studies; the count open now beside each. This study's row is marked.
First in 2014; this study’s year is marked. 4 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 34 is above the median of 30 across 394 interventional studies indexed under Gingival Recession.
Median enrollment 24 across the 36 interventional studies. Of the 8 that completed or were terminated, 1 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
Cairo University is the lead sponsor of 4,965 studies on the registry; 1,474 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
8 of the studies in Gingival Recession by Cairo University that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06643507Phase 3Cairo UniversityEvaluation of the Modified VISTA Technique Using ALB-PRF vs CTG in the Treatment of Multiple Miller Class III Recessions | 2026-12-20 |
| NCT07590375Phase 3Cairo UniversityTopical Phenytoin for Management of Gingival Recession | 2027-09-01 |
| NCT07520539Cairo UniversityAdding Effect of Cross-linked Hyaluronic Acid to Microneedling After Coronally Advanced Flap in Isolated RT1 Recession | 2026-12-01 |
| NCT07064603Cairo UniversityClinical Evaluation of (TCAF) Versus (CAF) Combined With Connective Tissue Graft in the Treatment of Multiple RT2 Gingival Recession Sites | 2026-12-01 |
| NCT07526259Cairo UniversityComparative Evaluation of Novel 3D Tunneling Technique Versus Modified Coronally Advanced Tunnel (MCAT) With Connective Tissue Graft in the Management of Multiple RT2 Gingival Recession | 2027-01-10 |
Add all 8 to your calendar (.ics) → With an account.
Among the 36 studies in Gingival Recession by Cairo University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized controlled clinical trial aims to evaluate and compare the clinical efficacy of the Mixed-Thickness Tunnel Access (MiTT) technique versus the Modified Coronally Advanced Tunnel (MCAT) technique, both combined with a subepithelial connective tissue graft (CTG), for the treatment of multiple adjacent Cairo Recession Type 2 (RT2) gingival recession defects.
The study is designed as a two-arm parallel, randomized clinical trial with a 1:1 allocation ratio, enrolling systemically healthy patients with multiple adjacent RT2 recessions. Participants will be randomly assigned to one of two groups:
Group A (Intervention): Patients treated with the Mixed-Thickness Tunnel Access (MiTT) technique combined with connective tissue graft.
Group B (Control): Patients treated with the Modified Coronally Advanced Tunnel (MCAT) technique combined with connective tissue graft.
The primary objective is to evaluate the reduction in gingival recession depth (GRD) over a 1-year follow-up period. Secondary outcomes include gingival recession width (GRW), percentage of mean root coverage (MRC %), probing pocket depth (PPD), clinical attachment level (CAL), gingival thickness (GT), keratinized tissue width (KTW), postoperative patient satisfaction, postoperative pain, and the root coverage esthetic score (RES).
This study seeks to provide evidence on whether the MiTT technique offers superior or comparable outcomes in managing complex RT2 recession defects.
Background and Rationale Gingival recession associated with interproximal attachment loss (Cairo RT2) presents a significant clinical challenge due to increased avascular surfaces, root prominence, and a reduced periosteal bed.
The Mixed-Thickness Tunnel Access (MiTT) technique introduces a hybrid approach combining full-thickness detachment in the keratinized gingiva to avoid fenestrations and maintain vascularization, with a split-thickness detachment apical to the mucogingival junction (MGJ) to maximize tissue mobility.
Surgical Protocols and Interventions Connective Tissue Graft (CTG) Harvesting: A standardized de-epithelialized free gingival graft (De-FGG) is harvested from the palate under magnification to obtain dense, stable connective tissue.
MiTT Group (Intervention): Involves two vertical mucosal incisions 1-2 mm apical to the MGJ lateral to the papilla base, split-thickness mucosal detachment apical to the MGJ, intrasulcular incisions, subperiosteal full-thickness tunnel elevation, graft insertion, and coronal advancement at least 1 mm coronal to the cemento-enamel junction (CEJ) secured with stabilizing sutures.
MCAT Group (Control): Involves initial sulcular incisions, muco-periosteal dissection extending beyond the MGJ and under each papilla, release of mucosal muscle fibers using Gracey curettes for passive coronal positioning, graft insertion, and flap suspension using horizontal mattress sutures around contact points.
Outcome Measures and Follow-Up Clinical parameters are evaluated by a blinded assessor at baseline, 3 months, 6 months, and 1 year postoperatively.
Assessed parameters include gingival recession depth (GRD), gingival recession width (GRW), percentage of mean root coverage (MRC %), probing pocket depth (PPD), clinical attachment level (CAL), gingival thickness (GT), keratinized tissue width (KTW), Visual Analogue Scale (VAS) scores for postoperative pain and patient satisfaction, and the Root Coverage Esthetic Score (RES).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Incisions: Perform two vertical mucosal incisions apical to the mucogingival junction (MGJ) lateral to the papilla base, alongside optional intrasulcular incisions up to one adjacent tooth. Detachment \& Access: Detach mucosa from muscles apical to the MGJ using tunnel instruments, then raise a full-thickness subperiosteal tunnel up to the gingival sulcus while keeping papilla tips intact. Graft Placement: Insert a harvested subepithelial connective tissue graft (CTG) and position it to cover the recession at least 1 mm coronal to the CEJ. Suturing: Anchor and coronally advance the tunnel suture, close vertical incisions, stabilize soft tissue with interrupted sutures, and remove sutures in 7 to 14 days.
Procedure: Mixed thickness tunnel access with connective tissue graft
Incisions \& Dissection: Initial sulcular incisions and flap separation are performed using a tunnel knife-elevator instrument. Muco-periosteal dissection extends beyond the muco-gingival junction (MGJ) and under each papilla to allow tension-free coronal movement. Muscle Release: Muscle fibers and remaining collagen bundles on the inner aspect of the flap's alveolar mucosa are carefully cut using Gracey curettes to avoid perforation and achieve passive coronal positioning. Graft Insertion \& Rinsing: The connective tissue graft (CTG) is inserted under the modified coronally advanced tunnel (MCAT) at recession sites and laterally retracted with sutures. The site is then rinsed with a saline solution to remove any clots. Flap Positioning: The flap is maintained slightly coronal to the cemento-enamel junction (CEJ) using suspended sutures around contact points, which position both the flap and CTG coronally.
Procedure: Modified Coronally Advanced Tunnel Technique with connective tissue graft
Mixed Thickness Tunnel Access with Connective Tissue Graft for root coverage
Modified Coronally Advanced Tunnel Technique with connective tissue graft for root coverage
Recession Depth change
Measured from the Cemento-enamel junction to the gingival margin at the midbuccal aspect of the tooth using a Hu-Friedy periodontal probe (UNC 15 periodontal probe, Hu-Friedy)
Time frame: Baseline, 3 months, 6 months, 12 months.
Gingival Recession Width
Horizontal measurement of the recession at the CEJ measured from the CEJ to the gingival margin at the midbuccal aspect of the tooth, using a Hu-Friedy periodontal probe (UNC 15 periodontal probe, Hu-Friedy).
Time frame: Baseline, 3 months, 6 months, 1 year.
Percentage of mean root coverage (MRC %)
(preoperative vertical recession - postoperative vertical recession/preoperative vertical recession) x 100.
Time frame: 6 months, 1 year
Probing pocket depth
Measured from the gingival margin to the base of the sulcus at the midbuccal aspect of the tooth measured from the CEJ to the gingival margin at the midbuccal aspect of the tooth using a Hu-Friedy periodontal probe (UNC 15 periodontal probe, Hu-Friedy).
Time frame: Baseline, 3 months, 6 months, 12 months.
Clinical attachment level (CAL):
Measured from the CEJ to the base of the sulcus at the midbuccal aspect of the tooth using a Hu-Friedy periodontal probe (UNC 15 periodontal probe, Hu-Friedy).
Time frame: Baseline, 3 months, 6 months, 12 months.
Gingival thickness (GT):
Transgingival piercing of the tissues horizontally 3 mm beneath the margin of the gingiva, perpendicular to the longitudinal axis of the tooth until it touches bone. Measured from the CEJ to the gingival margin at the midbuccal aspect of the tooth using a Hu-Friedy periodontal probe (UNC 15 periodontal probe, Hu-Friedy).
Time frame: Baseline, 3 months, 6 months, 12 months.
Keratinized tissue width (KTW):
From the gingival margin to the MGJ at the midbuccal aspect of the tooth. Measured from the CEJ to the gingival margin at the midbuccal aspect of the tooth using a Hu-Friedy periodontal probe (UNC 15 periodontal probe, Hu-Friedy).
Time frame: Baseline, 3 months, 6 months, 12 months.
Post operative patient satisfaction:
Patients will be asked about their satisfaction with the esthetic result, 6 months after the surgery. Visual analogue scale (VAS) scale will be used, with 0 indicating no esthetics and 100 the best possible esthetics.
Time frame: 1 year
Post- operative pain
The duration and the intensity of the patients pain perception will be measured in different established time points including the first 24 hours using the visual analogue scale (VAS=0-100)
Time frame: 2 and 4 hours after the surgery during the first 24 hours, every 8 hours the following 2 days, and daily late in the evening, for 1 week, or until the pain disappeared
Root coverage esthetic score:
The RES system evaluates five variables 6 months following surgery: gingival margin (GM), marginal tissue contour (MTC), soft tissue texture (STT), mucogingival junction (MGJ) alignment, and gingival color (GC). The clinical esthetic evaluation is performed without magnification. Zero, 3, or 6 points are used for the evaluation of the position of the gingival margin, whereas a score of 0 or 1 point is used for each of the other variables
Time frame: 6 months, 12 months
Plan to share: Undecided
No publications or documents are linked to this record.
Started Jul 2024 (actual). Primary completion is estimated for Jul 2027, 35 months after the start.
Of 236 non-industry interventional studies with no phase under Gingival Recession, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 30. This study's planned 35 months is above that.
Counting every sponsor, half of 238 studies reached it within 19 months; a quarter within 11 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.